The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...

A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...

MENLO PARK, Calif., Dec. 15, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management ...

CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...

The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...

By Kelly Peters,Special to Rice NewsAs artificial intelligence plays an increasingly prominent role in decoding DNA, tracking ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...